Our Clinical Evidence
Geneoscopy’s research and development are changing the way we approach gastrointestinal health through advanced diagnostics
Publications
Manuscripts
Cost-effectiveness of novel noninvasive screening tests for colorectal neoplasia
Noninvasive Stool RNA Test Approximates Disease Activity in Patients With Crohn’s Disease
Analytical Validation of the Multitarget Stool RNA Test for Colorectal Cancer Screening
CRC-PREVENT: Multi-target Stool RNA Test for Colorectal Cancer Screening
Multitarget Stool RNA Test for Noninvasive Detection of Colorectal Neoplasias in a Multicenter, Prospective, and Retrospective Cohort
Noninvasive Detection of High-Risk Adenomas Using Stool-Derived Eukaryotic RNA Sequences as Biomarkers
Posters
Development of a Second Generation Multi-Target Stool RNA Test (ColoSense 2.0) for Colorectal Cancer Screening
Stool-derived Eukaryotic RNA Assay Approximates Disease Activity Index and Predicts Therapeutic Response in Patients with Crohn’s Disease on Advanced Therapies
Stool-derived Eukaryotic RNA Biomarkers for Predicting Therapeutic Response and Monitoring Mucosal Healing for Patients with Inflammatory Bowel Disease
Cost Effectiveness Analysis of Novel RNA-Fit Test as a Strategy for CRC Screening in Average Risk U.S. Population
CRC-PREVENT: clinical validation study shows expedited and diverse recruitment for the non-invasive RNA-FIT test that can detect advanced colorectal neoplasia with high sensitivity
Prospective Study Using Virtual Enrollment to Access An RNA-FIT Assay for Non-invasive Detection of Colorectal Neoplasis